Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Onl

The FDA has issued a Class II recall for Accord Healthcare's Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, NDC 16729-449-17. The product was manufactured for Accord Healthcare by Intas Pharmaceuticals in India and is being recalled due to being a subpotent drug, according to the recall notice.

Most relevant for: patients taking levothyroxine sodium 75 mcg tablets from Accord Healthcare who may be receiving subpotent medication affecting their thyroid hormone replacement therapy

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.